SEC Comment Letter for GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416) (GALT) — Dec 8, 2009

GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416)
Date: Dec. 8, 2009 · CIK: 0001133416 · Accession: 0000000000-09-069168

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

December 8, 2009

Author

Joel Parker

Form

UPLOAD

Company

GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416)

Letter

Via Facsimile and U.S. Mail Mail Stop 4720 December 8, 2009 Theodore Zucconi Chief Executive Officer Pro-Pharmaceuticals, Inc. 7 Wells Avenue Newton, Massachusetts 02459

Re: Pro-Pharmaceuticals, Inc. Form 10-K for the Year Ended December 31, 2008 Form 10-Q for the Nine Months ended September 30, 2009 File No. 1-31791

Dear Mr. Zucconi:

We have completed our review of your Form 10-K and have no further comments at this time.

Sincerely, J o e l P a r k e r A c c o u n t i n g B r a n c h C h i e f

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 4720                                                                                                 December 8, 2009
Theodore Zucconi
Chief Executive Officer
Pro-Pharmaceuticals, Inc.
7 Wells Avenue
Newton, Massachusetts  02459

 Re: Pro-Pharmaceuticals, Inc.
  Form 10-K for the Year Ended December 31, 2008
  Form 10-Q for the Nine Months ended September 30, 2009
  File No. 1-31791

Dear Mr. Zucconi:

We have completed our review of your Form 10-K and have no further comments
at this time.

 Sincerely,            J o e l  P a r k e r          A c c o u n t i n g  B r a n c h  C h i e f

SecProbe.io